University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Peter Goadsby, M.B. B.S.

Neurologist and headache specialist

Dr. Peter Goadsby, a neurologist, specializes in the diagnosis and treatment of headache disorders, including migraines and cluster headache and other forms of chronic daily headache. He is director of the UCSF Headache Center and one of the world's leading headache experts and researchers.

Goadsby came to UCSF from the Institute of Neurology at University College London, National Hospital for Neurology and Neurosurgery and Hospital for Sick Children, Great Ormond Street, London, England. His research focuses on the mechanisms and management of head pain, with a special interest in migraine and trigeminal autonomic cephalalgias. His studies aim to understand the parts of the brain involved in headache and from this to derive new approaches to treatment. He earned a medical degree at the University of New South Wales School of Medicine, completed a residency in neurology at the Prince of Wales Hospital and completed a fellowship in neurology at the National Hospital for Nervous and Mental Diseases in London. He completed post-doctoral work in laboratories in New York and Paris.

Clinics

Headache Center
2330 Post St, 6th floor
San Francisco, CA 94115
Phone: (415) 353-8393
Fax: (415) 353-9539

Hours: Monday to Friday
9 a.m. – 5 p.m.

Conditions & Treatments

More about Peter Goadsby

Education

University of New South Wales Doctorate Program, Neurosciences 1983
University of New South Wales School of Medicine 1985

Residencies

Prince Henry, Prince of Wales Hospital, Medicine 1987
Prince Henry, Prince of Wales Hospital, Neurology 1988
Prince Henry, Prince of Wales Hospital, Clinical Neurophysiology 1989

Fellowships

National Hospital for Nervous and Mental Diseases, Neurology 1990

Selected Research and Publications

  1. Tso AR, Goadsby PJ. New targets for migraine therapy. Curr Treat Options Neurol. 2014 Nov; 16(11):318.
  2. Dodick DW, Goadsby PJ, Silberstein SD, Lipton RB, Olesen J, Ashina M, Wilks K, Kudrow D, Kroll R, Kohrman B, Bargar R, Hirman J, Smith J. Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol. 2014 Nov; 13(11):1100-7.
  3. Goadsby PJ. Hemicrania continua- Major Shortcomings in the new classification or rigid thinking is death to progress. J Headache Pain. 2014; 15(1):53.
  4. Dodick DW, Goadsby PJ, Spierings EL, Scherer JC, Sweeney SP, Grayzel DS. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2014 Sep; 13(9):885-92.
  5. Ho TW, Connor KM, Zhang Y, Pearlman E, Koppenhaver J, Fan X, Lines C, Edvinsson L, Goadsby PJ, Michelson D. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention. Neurology. 2014 Sep 9; 83(11):958-66.
  6. Martin PR, Reece J, Callan M, MacLeod C, Kaur A, Gregg K, Goadsby PJ. Behavioral management of the triggers of recurrent headache: A randomized controlled trial. Behav Res Ther. 2014 Oct; 61:1-11.
  7. Gelfand AA, Goadsby PJ. Medication overuse in children and adolescents. Curr Pain Headache Rep. 2014 Jul; 18(7):428.
  8. Viana M, Sainaghi PP, Stecco A, Mortara F, Sprenger T, Goadsby PJ. Headache in a patient with crowned dens: report of a new case. Headache. 2014 Jul; 54(7):1211-6.
  9. Goadsby PJ. Correction: Hemicrania continua- building on experience and clinical science. J Headache Pain. 2014; 15:29.
  10. Al-Hashel JY, Ahmed SF, Alroughani R, Goadsby PJ. Migraine among medical students in Kuwait University. J Headache Pain. 2014; 15:26.
  11. Schankin CJ, Maniyar FH, Sprenger T, Chou DE, Eller M, Goadsby PJ. The relation between migraine, typical migraine aura and "visual snow". Headache. 2014 Jun; 54(6):957-66.
  12. Maniyar FH, Sprenger T, Schankin C, Goadsby PJ. Photic hypersensitivity in the premonitory phase of migraine - a positron emission tomography study. Eur J Neurol. 2014 Sep; 21(9):1178-83.
  13. Goadsby PJ. Stress and migraine: Something expected, something unexpected. Neurology. 2014 Apr 22; 82(16):1388-9.
  14. Schankin CJ, Maniyar FH, Digre KB, Goadsby PJ. 'Visual snow' - a disorder distinct from persistent migraine aura. Brain. 2014 May; 137(Pt 5):1419-28.
  15. Goadsby PJ. Migraine-like features in cluster headache. Headache. 2014 Mar; 54(3):555.
  16. Hoffmann J, Akerman S, Goadsby PJ. Efficacy and mechanism of anticonvulsant drugs in migraine. Expert Rev Clin Pharmacol. 2014 Mar; 7(2):191-201.
  17. Hoffmann J, Goadsby PJ. Emerging targets in migraine. CNS Drugs. 2014 Jan; 28(1):11-7.
  18. Park J, Moon H, Akerman S, Holland PR, Lasalandra MP, Andreou AP, Ferrari MD, van den Maagdenberg AM, Goadsby PJ. Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: A Fos protein study. Neurobiol Dis. 2014 Apr; 64:1-7.
  19. Al-Hashel JY, Ahmed SF, Alroughani R, Goadsby PJ. Migraine misdiagnosis as a sinusitis, a delay that can last for many years. J Headache Pain. 2013; 14(1):97.
  20. Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014 Jan; 137(Pt 1):232-41.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.